Total target cash compensation shows a healthy increase at private life-science companies
Crossref DOI link: https://doi.org/10.1038/nbt.3166
Published Online: 2015-03-06
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rychlik, Bruce
Text and Data Mining valid from 2015-03-01
Article History
First Online: 6 March 2015
Competing interests
: The author declares no competing financial interests.